About Lixoft
Lixoft is a Healthcare company based in Antony (France) founded in 2011, and was acquired by Simulations Plus in April 2020. Modeling and simulation software for drug development is developed. Lixoft offers products and services including MonolixSuite, PKanalix, Monolix, and Simulx. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
The company was founded in 2011 and is based in Antony, France. Software solutions for model-based drug development and population analytics are provided, focusing on the pharmacometrics sector. Key products include Monolix for parameter estimation in non-linear mixed effects models, Mlxplore for visualization and exploration, Simulx for clinical trial simulation, and Datxplore for pre-data analysis. Consultancy, training, and support services are also offered.
- Headquarters Antony, France
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website lixoft.com
- Social LinkedIn X YouTube
- Acquired by Simulations Plus (Apr 2020)
- Investors
- Acquired bySimulations Plus
(Apr 2020)
Products & Services of Lixoft
Lixoft offers a comprehensive portfolio of products and services, including MonolixSuite, PKanalix, Monolix, and Simulx.
Software suite for drug development analysis and simulation tools.
Tool for non-compartmental and compartmental analysis in pharmacometrics.
Application for parameter estimation in non-linear mixed effect models.
Platform for clinical trial pharmacometrics modeling and scenarios.
Apps and channels of Lixoft
its YouTube channel MonolixSuite has 1.45K subscribers and 30 videos.
Videos from Lixoft
The most watched videos on Lixoft's YouTube channel, MonolixSuite (1.45K subscribers). Click a video to play it here.
More on MonolixSuite.
Investors in Lixoft
Lixoft has secured backing from 1 investor. Prominent investors backing the company include Simulations Plus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Simulation software is developed for chemoinformatics and drug discovery. | 1996 | simulations-plus.com | Lancaster, United States |
Investor details for Lixoft
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lixoft
2 dated milestones of Lixoft across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Lixoft is founded.
- Exit Acquired by Simulations Plus.
Web traffic of Lixoft
The website of Lixoft (lixoft.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 29.1% vs previous month
Websites whose visitors overlap most with Lixoft. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
raweb.inria.fr | raweb.inria.fr | 100% | – | ||
math.u-psud.fr | math.u-psud.fr | 98% | – | ||
| simulations-plus.com | 87% | 22.8K | #1,161,740 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lixoft
Complete news archive for Lixoft
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lixoft
Lixoft was founded in 2011.
Lixoft is headquartered in Antony, France. It is registered at Antony, Ile-de-france, France.
The company was founded in 2011 and is based in Antony, France. Software solutions for model-based drug development and population analytics are provided, focusing on the pharmacometrics sector. Key products include Monolix for parameter estimation in non-linear mixed effects models, Mlxplore for visualization and exploration, Simulx for clinical trial simulation, and Datxplore for pre-data analysis. Consultancy, training, and support services are also offered.
Lixoft offers MonolixSuite, PKanalix, Monolix, and Simulx.
Lixoft has 1 investor. Key investors include Simulations Plus.
Yes. Lixoft was acquired by Simulations Plus in April 2020.